News

Off-label use of eye drops containing bromfenac in the treatment of cystoid macular edema in the only seeing eye of a complex patient –⁠ case report

14. 6. 2024 Source: Treatment of Glaucoma

The following case report discusses the effect of repeated use of an ophthalmic preparation containing bromfenac in a patient with recurrent cystoid macular edema (CME) in the only seeing eye with advanced glaucoma. The patient has undergone more than 15 eye surgeries or procedures, has been treated for glaucoma since 2005, and has multiple intolerances to eye drops and polymorphic problems, which she attributes to the application of the drops. The dominant personality trait is an anxious approach, which, together with the complicated findings...

Impact of a Deep Learning Model Predicting Sepsis on Quality of Care and Survival

Early recognition of sepsis is crucial for better patient prognosis. The following study presents the positive impact of applying a deep learning model for early prediction of sepsis on the health…

13. 6. 2024 Source: proLékaře.cz

Somapacitan administered once weekly in the treatment of children with growth hormone deficiency –⁠ current understanding

Somapacitan is a long-acting derivative of recombinant human growth hormone approved for the treatment of children and adults with growth hormone (GH) deficiency. Dr. Reiko Horikawa from Japan's…

12. 6. 2024 Source: Growth Disorders

CASE STUDY: Oral Semaglutide in a Young Diabetic = Weight Loss and CV Risk Reduction, Better Adherence and Treatment Comfort

Diabetologist MUDr. Tomáš Pfohl from the Regional Hospital Liberec illustrates the benefits of therapy with oral semaglutide in a relatively young diabetic patient with type 2 DM after unsatisfactory…

10. 6. 2024 Source: Modern Treatment of Diabetes with GLP-1 Analogues

Evaluation of Joint Condition in Daily Practice in the Era of New Hemophilia Treatment

With the development of new treatment options for hemophilia, there has also been progress in methods for monitoring hemophilic arthropathy and identifying it in its early stages. In addition to…

10. 6. 2024 Source: Hemophilia

Collagen Turnover as a Biomarker of Hemophilia Treatment Efficacy

Over the past decades, hemophilia treatment has made significant progress—from factor therapy to prophylactic regimens and non-factor products, and even to gene therapy. Its development has greatly…

10. 6. 2024 Source: Hemophilia

Alarming Data on Prevalence and Insufficient Treatment of Hypertension in Working Age −⁠ Another Underestimated 'Civilization Epidemic'?

The National Cardiology Information System (NKIS), developed by the Czech Society of Cardiology in collaboration with the Institute of Health Information and Statistics (ÚZIS), has provided the first…

10. 6. 2024 Source: Risk factors of cardiovascular diseases

With Prof. Pavel Žák about Current Trends and Future Perspectives in Bone Marrow Transplantation and the Role of Carmustine in this Context

Hematopoietic stem cell transplantation has an indispensable place in the treatment of hemato-oncological diseases. We discuss current trends in this area, the significance and benefits of…

10. 6. 2024 Source: Oncological Treatment

Current Trends in Proton RT of Head and Neck Tumors: Aiming to Preserve T Lymphocytes, Without Them, Treatment is Ineffective

Tumors of the head and neck are often diagnosed at an advanced stage. With the availability of modern treatments, such as immunotherapy or radiotherapy modalities, prognosis and chances for long-term…

10. 6. 2024 Source: Proton Radiotherapy

What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?

A Spanish clinical study monitored the effect of administering probiotics as an adjunct therapy to non-surgical mechanical treatment of peri-implantitis. What did the study show regarding the effect…

7. 6. 2024 Source: Dental Care

X-ray in Dentistry: Who Can Indicate and Who Can Perform?

X-ray is an integral and important part of dental diagnostics. However, since it is also a source of ionizing radiation, its use is subject to legislative regulations that govern it.

4. 6. 2024 Source: Dental Care

Long-term survival of a 50-year-old man with metastatic pancreatic cancer on a combination of nal-IRI + 5-FU/LV in 2nd line treatment −⁠ case study

A recently published case study from the Czech Republic describes a patient with progression of pancreatic cancer following surgical treatment and adjuvant chemotherapy, who achieved a one-year…

3. 6. 2024 Source: Treatment of Gastrointestinal Carcinomas

1 … 9 10 11 12 13 … 115

Back Filter by speciality

Remove filters

Popular this week